Relgin 1 mg (Rasagiline)

Relgin 1 mg

Relgin 1mg Tablet, a MAO inhibitor, is used for the treatment of Parkinson’s disease which is caused by the lack of dopamine in the brain. This medicine works by boosting the level of dopamine, norepinephrine and serotonin in the brain. It helps by reducing the symptoms of this disease such as shakiness, stiffness and difficulty in moving.

Few side effects of this disease include dizziness, drowsiness, joint pain, heartburn, nausea, dry mouth, weight loss, and stomach pain. If these side effects worsen, contact your doctor immediately. There are few side effects which may occur rarely but are serious. These severe side effects include fainting, loss of balance, mood swings, muscle stiffness, swollen legs, bleeding or bruising, hallucinations and twitching. If you observe any of these side effects, it is advised to inform your doctor immediately. This drug may rarely cause allergic reactions such as rash, itching, swelling of face, throat, tongue, dizziness and trouble in breathing. It is best to seek medical help right away.

Do not use this medicine if you are allergic to it or the ingredients present in it. Inform your doctor about your current medications before using this medicine. If you have any medical problems such as heart disease, high blood pressure, liver disease, diabetes and sleep disorders, it is recommended to inform your doctor about the same. Also, tell your doctor if you are pregnant and breastfeeding before taking this medicine.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Psychiatrist before using this medicine.

Use

Parkinson’s Disease

Dosage

Relgin 0.5 Tablet
Relgin 1 mg Tablet

Side Effects

Joint Pain

Insomnia (Difficulty In Sleeping)

Dyspepsia

Influenza Like Symptoms

Depression

Cough

Peripheral Edema

Work

Though the exact mechanism of action of this medication is not known, it is supposed that it inhibits MAO-B, which results in the elevation of extracellular levels of dopamine in the striatum.